Setmelanotide: Revision history

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 April 2025

  • curprev 19:4519:45, 29 April 2025 Alara E. Dagsali talk contribs 23,681 bytes +23,681 Created page with "{{DrugProjectFormSinglePage |authorTag= Alara Ece Dagsali, M.D. |genericName=setmelanotide |aOrAn=a |drugClass=melanocortin-4 receptor (MC4R) agonist |indication=IMCIVREE is indicated for chronic weight management in adult and pediatric patients 6 years of age and older with monogenic or syndromic obesity due to: |adverseReactions=*'''Disturbance in Sexual Arousal''' *'''Depression and Suicidal Ideation''' *'''Hypersensitivity Reactions''' *'''Skin Pigme..."